Theravance Biopharma, Inc. (TBPH)

NASDAQ: TBPH · IEX Real-Time Price · USD
+0.05 (0.48%)
Nov 30, 2023, 11:52 AM EST - Market open

Theravance Biopharma Revenue

Theravance Biopharma had revenue of $54.51M in the twelve months ending September 30, 2023, with 5.55% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $15.69M with 26.04% year-over-year growth. In the year 2022, Theravance Biopharma had annual revenue of $51.35M, a decrease of -7.17%.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
524.37M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202251.35M-3.97M
Dec 31, 202155.31M-16.55M
Dec 31, 202071.86M-1.56M
Dec 31, 201973.41M13.04M
Dec 31, 201860.37M44.98M
Dec 31, 201715.39M-33.26M
Dec 31, 201648.65M6.52M
Dec 31, 201542.13M30.44M
Dec 31, 201411.69M11.46M
Dec 31, 2013226.00K-129.92M
Dec 31, 2012130.15M115.29M
Dec 31, 201114.85M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ModivCare 2.71B
Enhabit 1.05B
Atrion 168.60M
Wave Life Sciences 85.49M
SomaLogic 81.72M
OmniAb 64.69M
IRadimed 62.97M
Caribou Biosciences 34.61M
Revenue Rankings